STOCK TITAN

Prospect Capital Announces Annual Meeting Update

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Neutral)
Tags

Prospect Capital (NASDAQ: PSEC) held its adjourned annual meeting of stockholders on January 8, 2026. The proposals considered mirror those in the definitive proxy filed September 18, 2025.

As of September 17, 2025, outstanding shares included 465,087,009 common shares and multiple preferred series (examples: 26,232,644 Series A1; 23,857,330 Series A3; 6,961,866 Floating Rate Series A4; 2,143,366 Series A5; plus others). Common and preferred shares each carry one vote per share on matters for their class.

To allow additional solicitation of votes, the Annual Meeting is adjourned to January 15, 2026 at 4:00 p.m. ET, to be held online at www.virtualshareholdermeeting.com/PSEC2025.

Loading...
Loading translation...

Positive

  • None.

Negative

  • None.

Key Figures

Common shares outstanding 465,087,009 shares As of September 17, 2025 for Annual Meeting record date
Series A1 Preferred 26,232,644 shares 5.50% Series A1 Preferred Stock outstanding as of September 17, 2025
Series A Fixed Rate Preferred 5,251,157 shares 5.35% Series A Fixed Rate Cumulative Perpetual Preferred Stock outstanding
Series A3 Preferred 23,857,330 shares 6.50% Series A3 Preferred Stock outstanding as of September 17, 2025
Series A4 Floating Preferred 6,961,866 shares Floating Rate Series A4 Preferred Stock outstanding as of September 17, 2025
Series A5 Preferred 2,143,366 shares 7.50% Series A5 Preferred Stock outstanding as of September 17, 2025
Adjourned meeting date January 15, 2026, 4:00 p.m. ET New date/time for adjourned Annual Meeting
Virtual meeting link www.virtualshareholdermeeting.com/PSEC2025 Online location where the adjourned Annual Meeting will be held

Market Reality Check

$2.76 Last Close
Volume Volume 7,261,394 is 1.56x the 20-day average of 4,647,420, indicating elevated trading ahead of the adjourned meeting. high
Technical Shares at $2.75 are trading below the 200-day MA of $3.07 and about 38.48% under the 52-week high of $4.47.

Peers on Argus

PSEC was flat on the day, while key asset-management peers like GSBD, MFIC, OCSL, CSWC, and PX each gained around 3–4%. The lack of price move in PSEC versus broad peer strength suggests today’s annual-meeting update was viewed as company-specific and operational rather than a sector catalyst.

Historical Context

Date Event Sentiment Move Catalyst
Dec 16 Annual meeting update Neutral -2.0% Adjourned 2025 annual meeting to Jan 8, 2026 for additional proxy votes.
Nov 06 Quarterly earnings Positive +0.4% Reported NII, net income rebound, NAV and distributions for Sept 30, 2025 quarter.
Nov 05 Earnings call schedule Neutral -1.6% Announced timing and access details for Q1 earnings release and conference call.
Oct 28 Debt offering Neutral +0.4% Priced about $167M of 5.5% Series A senior unsecured notes due 2030.
Sep 08 New investment Neutral -0.3% Completed roughly $18M investment in The Ridge addiction treatment facility.
Pattern Detected

Recent PSEC news — including earnings, debt offerings, and prior meeting adjournments — has generally produced only modest single-day price moves, with limited directional follow-through.

Recent Company History

Over the past few months, PSEC updates have focused on capital structure, portfolio activity, and governance processes. The December 2025 annual meeting was previously adjourned to Jan 8, 2026 to gather more votes, mirroring today’s further adjournment. In November 2025, PSEC reported quarterly NII of $79.35M, NII per share of $0.17, and NAV of $6.45, while also issuing $167M of 5.5% notes due 2030. An $18M investment in The Ridge highlighted ongoing deployment into middle‑market credit. Viewed together, today’s notice continues an administrative governance theme rather than introducing new financial metrics.

Market Pulse Summary

This announcement updates shareholders that PSEC’s adjourned annual meeting has been further postponed to January 15, 2026 to allow more time to solicit votes on proposals described in the September 18, 2025 proxy statement. It reiterates the detailed common and preferred share counts as of September 17, 2025 and confirms equal voting rights within each class. Investors may focus on how final vote outcomes could influence governance or capital structure, while also tracking upcoming financial disclosures for a fuller picture.

Key Terms

proxy statement regulatory
"The proposals that were considered at the Annual Meeting are described in detail in the Company’s definitive proxy statement"
A proxy statement is a document companies send to shareholders ahead of a meeting that lays out the items up for a vote—like who will sit on the board, executive pay, and major corporate decisions—and provides background so shareholders can decide how to cast their votes or appoint someone to vote for them. Think of it as an agenda plus a ballot and briefing notes, important because the outcomes can change control, strategy, and value.
cumulative perpetual preferred stock financial
"5.35% Series A Fixed Rate Cumulative Perpetual Preferred Stock outstanding"
A cumulative perpetual preferred stock is a share that acts like a long-lasting hybrid between a bond and a dividend-paying stock: it promises regular fixed payments that, if missed, accumulate and must be paid later before common shareholders get dividends, and it has no set maturity date. Investors care because it can provide steady, higher-priority income similar to interest, but with limited capital upside, sensitivity to interest rates, and the risk that payments can be delayed even though they continue to accrue.
floating rate financial
"the Company’s Floating Rate Series A4 Preferred Stock outstanding"
An interest rate on a loan, bond or deposit that is not fixed but resets at regular intervals based on a reference market rate plus a set margin, so the payments rise or fall as overall interest rates change. For investors, floating-rate instruments act like a weather vane: they can protect income when rates climb by increasing payouts, but they introduce unpredictable cash flow and price movement when rates fall or shift, affecting expected yield and valuation.

AI-generated analysis. Not financial advice.

NEW YORK, Jan. 08, 2026 (GLOBE NEWSWIRE) -- Prospect Capital Corporation (NASDAQ: PSEC) (“Prospect”, “our”, or “we”) today announced that it held its adjourned annual meeting of stockholders (the “Annual Meeting”) on January 8, 2026. The proposals that were considered at the Annual Meeting are described in detail in the Company’s definitive proxy statement for the Annual Meeting as filed with the Securities and Exchange Commission on September 18, 2025 (the “Proxy”). As of September 17, 2025, there were 465,087,009 shares of the Company's common stock outstanding, 26,232,644 shares of the Company’s 5.50% Series A1 Preferred Stock outstanding, 163,000 shares of the Company’s 5.50% Series A2 Preferred Stock outstanding, 5,251,157 shares of the Company’s 5.35% Series A Fixed Rate Cumulative Perpetual Preferred Stock outstanding, 1,062,493 shares of the Company’s 5.50% Series M1 Preferred Stock outstanding, 23,857,330 shares of the Company’s 6.50% Series A3 Preferred Stock outstanding, 2,154,155 shares of the Company’s 6.50% Series M3 Preferred Stock outstanding, 6,961,866 shares of the Company’s Floating Rate Series A4 Preferred Stock outstanding, 2,208,807 shares of the Company’s Floating Rate Series M4 Preferred Stock outstanding, 2,143,366 shares of the Company’s 7.50% Series A5 Preferred Stock outstanding and 546,053 shares of the Company’s 7.50% Series M5 Preferred Stock outstanding. Each share of common stock is entitled to one vote on each matter to be voted on by holders of the common stock at the Annual Meeting, and each share of preferred stock is entitled to one vote on each matter to be voted on by holders of the preferred stock at the Annual Meeting. To afford additional time to solicit stockholder votes for the proposal found in the Proxy, the Annual Meeting has been adjourned until January 15, 2026, at 4:00 p.m., Eastern Time, at www.virtualshareholdermeeting.com/PSEC2025.

About Prospect Capital Corporation

Prospect is a business development company that primarily lends to and invests in middle market privately-held companies. Prospect’s investment objective is to generate both current income and long-term capital appreciation.

Prospect has elected to be treated as a business development company under the Investment Company Act of 1940. Prospect has elected to be treated as a regulated investment company under the Internal Revenue Code of 1986.

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, whose safe harbor for forward-looking statements does not apply to business development companies. Any such statements, other than statements of historical fact, are highly likely to be affected by other unknowable future events and conditions, including elements of the future that are or are not under our control, and that we may or may not have considered; accordingly, such statements cannot be guarantees or assurances of any aspect of future performance. Actual developments and results are highly likely to vary materially from any forward-looking statements. Such statements speak only as of the time when made, and we undertake no obligation to update any such statement now or in the future.

For additional information, contact:

Grier Eliasek, President and Chief Operating Officer
grier@prospectcap.com
Telephone (212) 448-0702


FAQ

When was Prospect Capital's adjourned annual meeting held and when is it reconvened (PSEC)?

The adjourned annual meeting was held on January 8, 2026 and reconvened on January 15, 2026 at 4:00 p.m. ET online.

How many common shares of Prospect Capital (PSEC) were outstanding as of September 17, 2025?

There were 465,087,009 common shares outstanding as of September 17, 2025.

Where will Prospect Capital's (PSEC) adjourned annual meeting on January 15, 2026 be held?

The meeting will be held virtually at www.virtualshareholdermeeting.com/PSEC2025.

Do preferred shares of Prospect Capital (PSEC) have voting rights at the annual meeting?

Yes; each share of preferred stock is entitled to one vote on matters voted on by preferred holders.

Which document describes the proposals considered at Prospect Capital's (PSEC) annual meeting?

The proposals are described in the company's definitive proxy filed September 18, 2025.
Prospect Capital

NASDAQ:PSEC

PSEC Rankings

PSEC Latest News

PSEC Latest SEC Filings

PSEC Stock Data

1.30B
337.89M
27.68%
14.96%
7.55%
Asset Management
Financial Services
Link
United States
NEW YORK